Adaptive Biotechnologies
ADPT
ADPT
147 hedge funds and large institutions have $2.7B invested in Adaptive Biotechnologies in 2020 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 73 increasing their positions, 24 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
4% more capital invested
Capital invested by funds: $2.58B → $2.7B (+$115M)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
22% less call options, than puts
Call options by funds: $2.77M | Put options by funds: $3.54M
Holders
147
Holding in Top 10
4
Calls
$2.77M
Puts
$3.54M
Top Buyers
| 1 | +$89.3M | |
| 2 | +$80.3M | |
| 3 | +$52M | |
| 4 |
BlackRock
New York
|
+$50.1M |
| 5 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$41.5M |
Top Sellers
| 1 | -$136M | |
| 2 | -$61.6M | |
| 3 | -$47.9M | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$15.9M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$12.7M |